Journal of Medicinal Chemistry p. 7396 - 7415 (2013)
Update date:2022-08-15
Topics:
Surivet, Jean-Philippe
Zumbrunn, Cornelia
Rueedi, Georg
Hubschwerlen, Christian
Bur, Daniel
Bruyère, Thierry
Locher, Hans
Ritz, Daniel
Keck, Wolfgang
Seiler, Peter
Kohl, Christopher
Gauvin, Jean-Christophe
Mirre, Azely
Kaegi, Verena
Dos Santos, Marina
Gaertner, Mika
Delers, Jonathan
Enderlin-Paput, Michel
Boehme, Maria
There is an urgent need for new antibacterial drugs that are effective against infections caused by multidrug-resistant pathogens. Novel nonfluoroquinolone inhibitors of bacterial type II topoisomerases (DNA gyrase and topoisomerase IV) have the potential
View Morewebsite:http://www.afinechem.com
Contact:+86-571-85134551
Address:No. 206 Zhen Hua Road, Hangzhou 310030, Zhejiang, China
puyang hongda shengdao new material co.,ltd.
Contact:+86-393- 4896278
Address:No.29 East Zhongyuan Road
Linyi Shengxin Pharmaceutical R&D Co., Ltd
Contact:+86-18653953873
Address:West First of Yufeng Road, Yishui County
website:http://www.enbridgepharm.com
Contact:+86-510-83591909
Address:Huishan Zone, Wuxi City, Jiangsu Province, P.R.China
shijiazhuang shuanglian chemical industry co.,ltd
Contact:0311-82190302
Address:Luquan Intersection , Shijiazhuang--Taiyuan Expressway,Shijiazhuang City
Doi:10.1016/j.tetlet.2006.02.043
(2006)Doi:10.1002/ejoc.201301657
(2014)Doi:10.3762/bjoc.12.86
(2016)Doi:10.1039/b515616e
(2006)Doi:10.1021/jo00178a036
(1984)Doi:10.1007/s11176-005-0266-2
(2005)